Related Experiment Videos
Teicoplanin in gram-positive infection: microbiological aspects
1Department of Bacteriology, Royal Hallamshire Hospital, Sheffield, UK.
European Journal of Haematology. Supplementum
|January 1, 1993
Summary
Teicoplanin offers an effective alternative to vancomycin for treating Gram-positive infections in neutropenic patients. This glycopeptide antibiotic reduces side effects and simplifies administration, improving patient care.
Area of Science:
- Infectious Diseases
- Pharmacology
- Hematology
Background:
- Indwelling catheters and Gram-negative infection treatment increase Gram-positive infections in neutropenic patients.
- Staphylococcus epidermidis is a common pathogen in these cases.
- Vancomycin use presents challenges like
Purpose of the Study:
- To evaluate teicoplanin as an alternative to vancomycin for Gram-positive infections.
- To compare the efficacy and safety profiles of teicoplanin and vancomycin.
- To explore strategies for reducing catheter-related infections.
Main Methods:
- Comparative analysis of teicoplanin and vancomycin efficacy.
- Assessment of adverse events, including nephrotoxicity and
Main Results:
- Teicoplanin demonstrates comparable efficacy to vancomycin.
- Teicoplanin avoids "red man" syndrome and is less nephrotoxic.
- Teicoplanin allows for simpler daily administration without routine serum monitoring.
Conclusions:
- Teicoplanin is a viable and advantageous alternative to vancomycin.
- Improved catheter care practices can further reduce infection rates.